Kentucky Center for Clinical and Translational Science
Kentucky Center for Clinical and Translational Science
批准号:
10185144
负责人:
Philip A Kern
金额:
$120.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-15 至 2021-05-31
关键词:
AbbreviationsAcademic Medical CentersAffectAgricultureAppalachian RegionArtsClinicalClinical ResearchClinical SciencesClinical TrialsClinical Trials NetworkCollaborationsCommunitiesDataDevelopmentDisciplineDiverse WorkforceEducationEngineeringEnvironmentFosteringFutureGoalsHealthHealthcareHealthcare SystemsHome environmentInformaticsInstitutesInstitutionInterdisciplinary StudyKentuckyLeadLeadershipLongevityMedical centerMethodologyMissionMulti-Institutional Clinical TrialParticipantPatient RecruitmentsPersonal SatisfactionPhasePopulationPositioning AttributeQuality of CareQuality of lifeResearchResearch TrainingRoleRuralRural CommunityRural PopulationScholarshipScienceSolidTarget PopulationsTranslational ResearchTrustUniversitiesWest VirginiaWorkforce Developmentbasebiomedical informaticscatalystclinical centercohesioncollaborative environmentcollegedata managementdata warehousedrug developmentfood environmenthealth care service organizationhealth disparityhealthcare communityimprovedinnovationmedical schoolsmedically underservednamed groupnovelnovel therapeuticsprogramsrural areasuccess
中文摘要
联系PD/PI:克恩、菲利普A
项目摘要
肯塔基州大学(英国)临床和转化科学中心(CCTS)创建了一个
临床和转化研究的综合之家,以促进科学进步和发现,
translational translation continuum的缩写。CCTS从根本上改变了研究环境,
只有在英国,但整个中央阿巴拉契亚通过发展一个强大的研究网络,
阿巴拉契亚转化研究网络(ATRN),与综合研究伙伴关系,包括其他
CTSA中心结合对独特而严重的健康挑战的深入了解,
面对阿巴拉契亚中部的居民,英国CCTS的定位是领导地方,地区和国家
重点关注这一人群中显著的健康差异的研究工作。我们的首要目标是,
CTSA中心将继续支持全方位临床和转化研究的创新,
教育未来的劳动力,让我们的社区参与生物医学科学,并与
国家网络,以推进有凝聚力的多中心临床试验,这将最终提高健康和
中阿巴拉契亚人民的生活质量。具体而言,英国CCTS将:1)领导机构
在提供高效,有效的临床和转化研究方面的创新。2)发展多样化的
跨多个学科的劳动力,推进转化研究,并在团队协作为基础的科学擅长。
3)通过与我们的社区广泛合作,满足阿巴拉契亚中部居民的独特需求。
区域、农村和社区伙伴。4)促进创新研究,包括新药
发展和信息学方法,特别注重为特殊人群带来创新
和整个生命周期。5)建立一个高效的临床试验网络,以英国为中心,并延伸到我们的
合作伙伴医疗保健系统,将成为CTSA联盟的重要和领先组成部分,包括
参与者遍及阿巴拉契亚中部农村的四个州。英国CCTS受益于
只有少数大学校园里才有这样的协作环境。英国有16所学院,其中11所涉及
英国CCTS(包括六个生物医学学院)在一个中央校园。我们的身体距离
学术界和卫生保健界,沿着合作文化,创造了一个紧密团结的统一
学术界和立场英国CCTS,以证明合作翻译的影响,
团队科学的研究和领导力。我们的努力已经成功地改变了文化
从英国学术医学中心的一个更敏锐地欣赏奖学金,创新和
转化科学我们现在计划在这些优势的基础上将转化科学推进到下一个
随着我们临床试验网络的进一步发展,新的信息学项目的开发,
在整个地区继续发展劳动力。这些努力将有利于医学
服务不足的阿巴拉契亚中部居民,并将大大有助于国家CTSA计划。
1
项目摘要/摘要第287页
联系PD/PI:克恩、菲利普A
英文摘要
Contact PD/PI: Kern, Philip A
PROJECT SUMMARY
The University of Kentucky (UK) Center for Clinical and Translational Science (CCTS) has created an
integrated home for clinical and translational research to promote scientific progress and discoveries at every
phase of the translational continuum. The CCTS has fundamentally transformed the research environment not
only at UK but throughout Central Appalachia through the development of a strong research network, the
Appalachian Translational Research Network (ATRN), with integrated research partnerships including other
CTSA hubs. When combined with an in-depth understanding of the unique and serious health challenges
faced by Central Appalachian residents, the UK CCTS is positioned to lead local, regional and national
research efforts that focus on the significant health disparities in this population. Our overarching goal as a
CTSA hub is to continue to champion innovation in the full spectrum of clinical and translational research while
educating the workforce of the future, engaging our communities in biomedical science and working with the
national network to advance cohesive multi-center clinical trials, which will ultimately elevate the health and
quality of life of the populace of Central Appalachia. Specifically, the UK CCTS will: 1) Lead institutional
innovation in the delivery of efficient, effective clinical and translational research. 2) Develop a diverse
workforce across multiple disciplines that advances translational research and excels in team-based science.
3) Meet the unique needs of Central Appalachian residents by extensively engaging and collaborating with our
regional, rural and community-based partners. 4) Catalyze innovative research, including novel drug
development and informatics methodologies, with particular focus on bringing innovation to special populations
and across the lifespan. 5) Create an efficient clinical trials network, centered at UK, and extending into our
partner health care systems that will be an essential and leading component of the CTSA consortium, involving
participants throughout a four state region of rural Central Appalachia. The UK CCTS benefits from a
collaborative environment found on only a few university campuses. UK has 16 colleges, with 11 involved in
the UK CCTS (including six biomedical colleges) on one central campus. This physical proximity of our
academic and health care communities, along with a culture of collaboration, creates a closely knit unified
academic community and positions the UK CCTS to demonstrate the impact of collaborative translational
research and leadership in team science. Our efforts have already been successful at transforming the culture
of the UK academic medical center to one that more keenly appreciates scholarship, innovation and
translational science. We now plan to build on these strengths to advance translational science to the next
level, with further development of our clinical trial networks, development of novel informatics programs, and
continued development of the workforce throughout the region. These efforts will benefit the medically
underserved residents of Central Appalachia and will significantly contribute to the national CTSA program.
1
Project Summary/Abstract Page 287
Contact PD/PI: Kern, Philip A
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mirabegron and tadalafil effectiveness for treatment of prediabetes
-
批准号:10363388
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2021
-
负责人:Philip A Kern
-
依托单位:
Mirabegron and tadalafil effectiveness for treatment of prediabetes
-
批准号:10532229
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2021
-
负责人:Philip A Kern
-
依托单位:
Mechanisms for activation of beige adipose tissue in humans
-
批准号:10531210
-
项目类别:
-
资助金额:$60.91万
-
财政年份:2020
-
负责人:Philip A Kern
-
依托单位:
Mechanisms for Activation of Beige Adipose Tissue in Humans; Supplement
-
批准号:10630687
-
项目类别:
-
资助金额:$47.25万
-
财政年份:2020
-
负责人:Philip A Kern
-
依托单位:
Mechanisms for activation of beige adipose tissue in humans
-
批准号:10308496
-
项目类别:
-
资助金额:$60.91万
-
财政年份:2020
-
负责人:Philip A Kern
-
依托单位:
The activation of brown and beige fat and role in insulin sensitivity
-
批准号:9241565
-
项目类别:
-
资助金额:$54.41万
-
财政年份:2016
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:10459638
-
项目类别:
-
资助金额:$331.99万
-
财政年份:2016
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:10681386
-
项目类别:
-
资助金额:$331.99万
-
财政年份:2016
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:9314011
-
项目类别:
-
资助金额:$364.53万
-
财政年份:2016
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:10733214
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2016
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:10405236
-
项目类别:
-
资助金额:$331.99万
-
财政年份:2016
-
负责人:Philip A Kern
-
依托单位:
Cold Induced Changed in Human Subcutaneous White Adipose
-
批准号:9321959
-
项目类别:
-
资助金额:$50.89万
-
财政年份:2015
-
负责人:Philip A Kern
-
依托单位:
Cold Induced Changed in Human Subcutaneous White Adipose
-
批准号:9008664
-
项目类别:
-
资助金额:$51.89万
-
财政年份:2015
-
负责人:Philip A Kern
-
依托单位:
Dietary fat, lipoproteins, and lipopolysaccharide: role in insulin resistance
-
批准号:8835108
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2014
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:8269774
-
项目类别:
-
资助金额:$335.32万
-
财政年份:2011
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:8866250
-
项目类别:
-
资助金额:$339.48万
-
财政年份:2011
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:8262003
-
项目类别:
-
资助金额:$16.06万
-
财政年份:2011
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:8269769
-
项目类别:
-
资助金额:$15.01万
-
财政年份:2011
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:8637113
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2011
-
负责人:Philip A Kern
-
依托单位:
Kentucky Center for Clinical and Translational Science
-
批准号:8262002
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2011
-
负责人:Philip A Kern
-
依托单位:
海外基金